Free Newsletter
Baxter's Preflucel gets EU OK
Baxter International has received the approval of a European repeat mutual recognition procedure by the Austrian Agency for Health and Food Safety for the Preflucel seasonal influenza vaccine. The 13 participating EU countries, including Germany, Spain, UK and Nordic countries, will formally implement the license on a national level to make Preflucel available for the 2011-12 influenza season. Baxter release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
SHARE
WITH: